Benefits
Thicker hair growth in women
In a 12-week trial in 90 women with thinning hair, the high dose shifted scalp hairs from fine vellus hairs toward thicker terminal hairs compared with placebo, measured by TrichoScan from week 3. The lower-biotin dose did not differ from placebo. This is a single trial funded by the ingredient's developer and has not been repeated.
Skin smoothness and wrinkle depth
In the same trial, maximum wrinkle depth fell with the high dose compared with placebo by week 12, measured with a 3D skin camera. Fine lines (both doses) and texture (high dose) improved from baseline, but those changes were not shown to beat placebo, and skin elasticity did not differ between groups. One developer-funded study.
Mechanism of action
Biotin and keratin
Biotin is a cofactor for carboxylase enzymes in hair roots and is linked to keratin formation. Deficiency causes hair loss and brittle nails, but published support for biotin in people without deficiency is limited to a few case reports and small studies.
Silicon and connective tissue
Silicon is suggested to support collagen formation and skin strength, and higher hair silicon has been linked to less hair loss. Silicon supplements differ widely in absorption depending on chemical form, and clinical studies of their safety and efficacy are still lacking.
Hair-growth signals in rats
In shaved rats, arginine silicate with or without magnesium biotinate increased hair density, the share of growing hair follicles and growth signals such as VEGF; IGF-1 rose only in the groups that also received magnesium biotinate. Arginine silicate alone did not affect nail growth; the combination with the higher biotin dose did. Animal data only.
Magnesium biotinate as a biotin source
The developer presents magnesium biotinate as a better-absorbed form of biotin, citing animal studies of tissue uptake. No human comparison with ordinary biotin is cited here.
Clinical trials
Randomized, double-blind, placebo-controlled trial of three arms for 12 weeks: high dose (10 mg biotin plus 10 mg silicon a day), low dose (3 mg biotin plus 10 mg silicon) and placebo. Funded by JDS Therapeutics; the authors work for the contract research organization that oversaw the study. Not indexed in PubMed. (Kalman et al. 2021, J Clin Exp Dermatol Res)
90 healthy women aged 21 to 65 with self-reported thinning hair confirmed on the Savin/Ludwig scale; 30 per group.
The high dose improved the ratio of vellus to terminal hairs versus placebo from week 3 to week 12 (p=0.029) and reduced maximum wrinkle depth at week 12 (p=0.031). Skin elasticity did not differ, nail ratings improved in all groups including placebo, and the low dose did not reach significance on most measures. No adverse events were linked to the product.